Kasper Tudor
Head of Investor Relations
Replay available
Waters Corporation (NYSE: WAT) Q2 2025 earnings conference call, held 2025-08-04. Replay captured from the company's public earnings webcast.

Head of Investor Relations
President and Chief Executive Officer
Senior Vice President and Chief Financial Officer
Analyst, Nefron
Analyst, Jefferies
Analyst, JPMorgan
Analyst, Lirink
Analyst, Scotiabank
Watch the replay and follow the connected company analysis, news, and investor updates for Waters Corporation.
WEBVTT 00:00:00.031 -- 00:00:05.478 Welcome to the Waters Corporation second quarter 2025 financial results conference call. 00:00:05.478 -- 00:00:09.963 All participants will be in listen-only mode until the question and answer session begins. 00:00:09.963 -- 00:00:14.829 This call is being recorded. If anyone has objections, please disconnect at this time. 00:00:14.829 -- 00:00:17.052 It is now my pleasure to turn the call over to Mr. 00:00:17.052 -- 00:00:21.936 Caspar Tudor, head of investor relations. Please go ahead, sir. 00:00:22.118 -- 00:00:24.521 Thank you, Leila, and good morning, everyone. 00:00:24.521 -- 00:00:27.858 Welcome to Waters Corporation's second quarter earnings call. 00:00:27.858 -- 00:00:33.045 Joining me today are Dr. Udit Batra, our President and Chief Executive Officer, and Amol 00:00:33.045 -- 00:00:36.771 Charbul, our Senior Vice President and Chief Financial Officer. 00:00:36.771 -- 00:00:40.296 Before we begin, I will cover the cautionary language. 00:00:40.296 -- 00:00:44.021 In this conference call, we will make forward-looking statements regarding future events 00:00:44.021 -- 00:00:46.605 or future financial performance of the company. 00:00:46.605 -- 00:00:51.031 We will provide guidance regarding possible future results as well as commentary on potential 00:00:51.031 -- 00:00:56.078 market and business conditions that may impact Waters Corporation during 2025 and 00:00:56.078 -- 00:01:01.474 beyond. Additionally, we'll comment on the expected timing for completion of Waters' 00:01:01.474 -- 00:01:06.327 pending combination with the Biosciences and Diagnostic Solutions business of Becton 00:01:06.327 -- 00:01:10.479 Dickinson and Company, as well as the expected financial and operational impact of this 00:01:10.479 -- 00:01:15.560...